About Us

Why We Exist

Apimeds is redefining intelligent medicine—where clinical judgment, scientific rigor, and human insight guide every decision. We are advancing a non-narcotic therapeutic for high-need conditions, Apitox, a novel agent derived from purified honey bee venom.

At the heart of our work is a bold commitment to actual intelligence (ai²): the synthesis of expert knowledge and purposeful strategy that drives how we build, acquire, and advance meaningful therapies.

A Company Built for Tomorrow

Apimeds US is publicly traded on the New York Stock Exchange (Ticker: APUS) and led by a team of experienced biopharma professionals committed to delivering meaningful healthcare advancements. We are actively pursuing licensing and acquisition opportunities to grow our pipeline and expand our impact.

a medical professional is seated next to an elderly man and woman, engaged in discussion

Our Mission

Advancing healthcare via critical thinkers and dedicated scientists

in order to

provide the healthcare community advancements that improve quality of life

allowing 

patients to believe in Apimeds as a source of hope

and delivering

physicians a vehicle for advancing the science of treatment

Our Values

  • Dedicated to Patients

    Dedicated to Patients

    Real needs, real lives—our therapies begin there.

  • Science with Integrity

    Science with Integrity

    We follow the data—openly, ethically, always.

  • Visionary Growth

    Visionary Growth

    Ambition backed by strategy. Growth powered by vision.

  • Collaborative Excellence

    Collaborative Excellence

    We build smarter, faster—together.

  • Agility in Action

    Agility in Action

    We move fast, think sharp, and act with purpose.